financetom
Business
financetom
/
Business
/
RBC Capital Markets Outlines Top Ideas In Canadian Exploration, Production Sector
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RBC Capital Markets Outlines Top Ideas In Canadian Exploration, Production Sector
Apr 11, 2024 7:50 AM

10:35 AM EDT, 04/11/2024 (MT Newswires) -- RBC Capital Markets outlined Thursday its top ideas in the Canadian exploration and production sector with the Q1 2024 reporting season due to kick off on April 22 with PrairieSky Royalty ( PREKF ) providing results after market close.

Among top ideas, RBC cited ARC Resources Ltd. ( AETUF ) , Obsidian Energy Ltd. ( OBE ) , Topaz Energy Corp. ( TPZEF ) and Tourmaline Oil Corp. ( TRMLF ) .

RBC said its top ideas list include names that are best positioned with respect to operational sustainability, RoC metrics and asset quality. But RBC noted that the companies on the list are not necessarily with the most "torque" to commodity prices.

With capital allocation top of mind, RBC's estimates incorporate $13.6-$14.8 billion in 2024E/25E capital spend, mapping to $8.7-$8.9 billion in FCF (9%-9% FCF yields, or 9%-12% at strip). RBC expects buybacks/dividends to remain the primary outlay for FCF beyond debt reduction, with 85%-63% of the group utilizing buybacks/dividends. It noted public filings point to material buybacks executed by NuVista (3.9mm shares, $44mm), Advantage (2.8mm shares, $24.9mm), Crescent Point (923k shares, $10mm), and ARC (750k shares, $16mm). RBC believes "meaningful capex cuts are unlikely given continued robust liquids pricing".

RBC expects the first quarter of Canadian exploration and production companies to be "largely drama-free," with key themes to watch including free cash outlook and the impact on RoC programs ("with oil and liquids-rich producers having a distinct advantage") and capex management in the context of lower natural gas prices, but higher liquids.

Price: 25.91, Change: -0.23, Percent Change: -0.88

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved